OrthoPediatrics is an American bio-science company engaged in designing, developing, manufacturing, and distributing orthopedic implants and instruments for pediatric issues. It is based in Warsaw, Indiana.
| trading_symbol | registrant_name | time | price | change | percentage_change |
|---|---|---|---|---|---|
| KIDS | ORTHOPEDIATRICS CORP | 2026-04-02 15:10:04 | 16.06 | 0 | 0 |
| trading_symbol | central_index_key | registrant_name | isin_number | lei_number | ein_number | exchange | sic_code | sic_description | fiscal_year_end | state_of_incorporation | address_street | address_city | address_state | address_zip_code | address_country | address_country_code | phone_number | mailing_address | business_address | former_name | industry | founding_date | chief_executive_officer | number_of_employees | website | market_cap | shares_issued | shares_outstanding | description | update_time |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| KIDS | 0001425450 | ORTHOPEDIATRICS CORP | US68752L1008 | 5493000KUTPFGOPAT717 | 261761833 | Nasdaq | 3841 | Surgical & Medical Instruments & Apparatus | 1231 | — | 2850 FRONTIER DRIVE | WARSAW | IN | 46582 | UNITED STATES | US | 574-268-6379 | 2850 FRONTIER DRIVE, WARSAW, IN, 46582 | 2850 FRONTIER DRIVE, WARSAW, IN, 46582 | — | — | 2006 | — | — | — | 362,500,000 | 25,093,792 | 25,278,787 | OrthoPediatrics is an American bio-science company engaged in designing, developing, manufacturing, and distributing orthopedic implants and instruments for pediatric issues. It is based in Warsaw, Indiana. | 2026-04-02 18:08:38 |
| Fiscal Year | Market Cap | Change In Market Cap | Percentage Change In Market Cap | Shares Outstanding | Change In Shares Outstanding | Percentage Change In Shares Outstanding |
|---|---|---|---|---|---|---|
| 2025 | 362,500,000 | 99,100,000 | 37.6234 | 25,278,787 | 992,197 | 4.0854 |
| 2024 | 263,400,000 | -181,700,000 | -40.8223 | 24,286,590 | 737,094 | 3.13 |
| 2023 | 445,100,000 | -26,400,000 | -5.5992 | 23,549,496 | 556,050 | 2.4183 |
| Executive Name | Executive Position | Fiscal Year | Salary | Bonus | Stock Awards | Incentive Plan Compensation | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Gregory A. Odle | President | 2024 | 368,000 | — | 1,040,050 | 179,755 | 13,187 | 1,600,992 |
| Daniel J. Gerritzen | Secretary, Executive Vice President, General Counsel | 2024 | 368,000 | — | 1,040,050 | 179,755 | 12,153 | 1,599,958 |
| David R. Bailey | Chief Executive Officer, President | 2024 | 550,000 | — | 2,693,771 | 402,984 | 10,133 | 3,656,888 |
| Fred L. Hite | Chief Financial Officer, Chief Operating Officer | 2024 | 501,000 | — | 1,699,136 | 367,082 | 13,800 | 2,581,018 |
| Joseph W. Hauser | President | 2024 | 400,000 | — | 1,130,493 | 195,386 | 13,800 | 1,739,679 |
| Fiscal Year | Employee Count |
|---|---|
| 2025 | 602 |
| 2024 | 562 |
| 2023 | 247 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | 236,348,000 | 204,727,000 | 148,732,000 |
| Cost Of Revenue | 63,687,000 | 56,129,000 | 37,479,000 |
| Gross Profit | 172,661,000 | 148,598,000 | 111,253,000 |
| Research And Development Expenses | 9,102,000 | 11,034,000 | 10,196,000 |
| General And Administrative Expenses | 119,832,000 | 102,789,000 | 75,421,000 |
| Operating Expenses | 211,899,000 | 183,608,000 | 138,004,000 |
| Operating Income | -39,238,000 | -35,010,000 | -26,751,000 |
| Net Income | -39,648,000 | -37,822,000 | -20,974,000 |
| Earnings Per Share Basic | -1.69 | -1.64 | -0.92 |
| Earnings Per Share Diluted | -1.69 | -1.64 | -0.92 |
| Weighted Average Shares Outstanding Basic | 23,459,425 | 23,077,704 | 22,675,477 |
| Weighted Average Shares Outstanding Diluted | 23,459,425 | 23,077,704 | 22,675,477 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Cash And Cash Equivalents | 19,556,000 | 43,820,000 | 31,055,000 |
| Marketable Securities Current | 41,295,000 | 25,013,000 | 49,251,000 |
| Accounts Receivable | 53,838,000 | 42,357,000 | 34,617,000 |
| Inventories | 133,790,000 | 117,005,000 | 105,851,000 |
| Non Trade Receivables | — | — | — |
| Other Assets Current | — | — | — |
| Total Assets Current | 256,419,000 | 237,173,000 | 226,496,000 |
| Marketable Securities Non Current | — | — | — |
| Property Plant And Equipment | 49,555,000 | 50,596,000 | 41,048,000 |
| Other Assets Non Current | 15,676,000 | 10,417,000 | 2,940,000 |
| Total Assets Non Current | 252,211,000 | 236,036,000 | 212,249,000 |
| Total Assets | 508,630,000 | 473,209,000 | 438,745,000 |
| Accounts Payable | 18,786,000 | 8,908,000 | 12,649,000 |
| Deferred Revenue | — | — | — |
| Short Term Debt | 1,866,000 | 897,000 | 152,000 |
| Other Liabilities Current | 11,354,000 | 9,659,000 | 7,391,000 |
| Total Liabilities Current | 46,197,000 | 33,962,000 | 41,666,000 |
| Long Term Debt | 106,010,000 | 77,483,000 | 11,063,000 |
| Other Liabilities Non Current | 9,537,000 | 5,892,000 | 1,112,000 |
| Total Liabilities Non Current | 115,837,000 | 84,681,000 | 20,054,000 |
| Total Liabilities | 162,034,000 | 118,643,000 | 61,720,000 |
| Common Stock | 6,000 | 6,000 | 6,000 |
| Retained Earnings | -275,212,000 | -235,564,000 | -197,742,000 |
| Accumulated Other Comprehensive Income | -523,000 | -10,773,000 | -5,526,000 |
| Total Shareholders Equity | 346,596,000 | 354,566,000 | 377,025,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Depreciation And Amortization | 21,119,000 | 19,080,000 | 17,385,000 |
| Share Based Compensation Expense | 17,778,000 | 13,548,000 | 10,526,000 |
| Other Non Cash Income Expense | — | — | — |
| Change In Accounts Receivable | 9,366,000 | 4,749,000 | 9,724,000 |
| Change In Inventories | 8,469,000 | 13,197,000 | 26,279,000 |
| Change In Non Trade Receivables | — | — | — |
| Change In Other Assets | — | — | — |
| Change In Accounts Payable | 8,167,000 | -4,280,000 | 1,491,000 |
| Change In Other Liabilities | 2,786,000 | -315,000 | 4,631,000 |
| Cash From Operating Activities | -4,851,000 | -27,048,000 | -27,046,000 |
| Purchases Of Marketable Securities | 15,000,000 | 25,000,000 | 48,600,000 |
| Sales Of Marketable Securities | 0 | 49,855,000 | 112,904,000 |
| Acquisition Of Property Plant And Equipment | 11,110,000 | 14,263,000 | 16,878,000 |
| Acquisition Of Business | 0 | 20,225,000 | 0 |
| Other Investing Activities | — | — | — |
| Cash From Investing Activities | -43,629,000 | -13,162,000 | 41,677,000 |
| Tax Withholding For Share Based Compensation | — | — | — |
| Payments Of Dividends | — | — | — |
| Issuance Of Common Stock | — | 0 | 0 |
| Repurchase Of Common Stock | — | — | — |
| Issuance Of Long Term Debt | — | — | 0 |
| Repayment Of Long Term Debt | 16,000 | 16,000 | 16,000 |
| Other Financing Activities | — | — | — |
| Cash From Financing Activities | 23,975,000 | 53,135,000 | 7,301,000 |
| Change In Cash | -24,157,000 | 12,750,000 | 22,565,000 |
| Cash At End Of Period | 19,556,000 | 43,820,000 | 31,055,000 |
| Income Taxes Paid | 171,000 | — | — |
| Interest Paid | 6,516,000 | 2,752,000 | 42,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Earnings Per Share | -1.69 | -1.64 | -0.92 |
| Price To Earnings Ratio | -10.5089 | -14.1341 | -35.337 |
| Earnings Growth Rate | 3.0488 | 78.2609 | -1,633.3333 |
| Price Earnings To Growth Ratio | -3.4469 | -0.1806 | 0.0216 |
| Book Value Per Share | 14.7743 | 15.364 | 16.627 |
| Price To Book Ratio | 1.2021 | 1.5087 | 1.9553 |
| Ebitda | -18,331,000 | -18,707,000 | -3,547,000 |
| Enterprise Value | 504,959,388 | 569,501,178.72 | 717,339,757.27 |
| Dividend Yield | — | — | — |
| Dividend Payout Ratio | — | — | — |
| Debt To Equity Ratio | 0.3112 | 0.2211 | 0.0297 |
| Capital Expenditures | 20,078,000 | 28,628,000 | 24,147,000 |
| Free Cash Flow | -24,929,000 | -55,676,000 | -51,193,000 |
| Return On Equity | -0.1144 | -0.1067 | -0.0556 |
| One Year Beta | 1.0492 | 1.1466 | 1.5132 |
| Three Year Beta | 1.179 | 1.2931 | 1.2383 |
| Five Year Beta | 1.1763 | 1.0744 | 1.0868 |
| Insider Name | Relationship To Issuer | Transaction Date | Amount Of Securities | Acquired Or Disposed | Securities Owned Following Transaction |
|---|---|---|---|---|---|
| Gerritzen Daniel J | General Counsel and Secretary | 2026-03-16 | 8,614 | D | 149,533 |
| Odle Gregory A | President of Scoliosis | 2026-03-16 | 8,433 | D | 187,735 |
| Bailey David R | Director, President and CEO | 2026-03-16 | 19,535 | D | 298,020 |
| Hite Fred | Director, COO and CFO | 2026-03-16 | 12,993 | D | 277,477 |
| Hauser Joseph W | Pres. Trauma & Def. Correction | 2026-03-16 | 8,596 | D | 194,767 |
| Investor Name | Period Of Report | Market Value | Amount Of Securities | Price Per Security |
|---|---|---|---|---|
| GOLDMAN SACHS GROUP INC | 2025-12-31 | 3,092,833 | 174,146 | 17.76 |
| Caitong International Asset Management Co., Ltd | 2025-12-31 | 18 | 1 | 18 |
| Invesco Ltd. | 2025-12-31 | 692,676 | 39,002 | 17.76 |
| ADAR1 Capital Management, LLC | 2025-12-31 | 352,447 | 19,845 | 17.76 |
| BRAIDWELL LP | 2025-12-31 | 19,542,571 | 1,100,370 | 17.76 |
| Registrant Name | Period Of Report | Fund Name | Fund Symbol | Amount Of Units | Value In Usd | Percentage Value Compared To Assets |
|---|---|---|---|---|---|---|
| Global X Funds | 2026-01-31 | Global X Russell 2000 ETF | RSSL | 7,614 | 132,940.44 | 0.0096 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 2026-01-31 | Invesco RAFI US 1500 Small-Mid ETF | PRFZ | 21,587 | 376,909.02 | 0.0141 |
| ProFunds | 2026-01-31 | SMALL-CAP PROFUND SERVICE CLASS | SLPSX | 18 | 314.28 | 0.0042 |
| ProFunds | 2026-01-31 | SMALL-CAP PROFUND INVESTOR CLASS | SLPIX | 18 | 314.28 | 0.0042 |
| ProFunds | 2026-01-31 | ULTRASMALL-CAP PROFUND SERVICE CLASS | UAPSX | 216 | 3,771.36 | 0.0071 |